Common anti-haemostatic medications increase the severity of systemic infection by uropathogenic Escherichia coli

Common anti-haemostatic medications increase the severity of systemic infection by uropathogenic Escherichia coli.

Full text not available from this repository.
Item Type: Article
Status: Published
Official URL: https://doi.org/10.1016/j.micres.2021.126918
Journal or Publication Title: Microbiological Research
Volume: 254
Page Range: p. 126918
Date: 2022
Divisions: Tuberculosis
Depositing User: General Admin
Identification Number: 10.1016/j.micres.2021.126918
ISSN: 09445013
Date Deposited: 17 Mar 2022 01:55
Abstract:

Uropathogenic Escherichia coli (UPEC) causes urinary tract infections that can result in sepsis. The haemostatic system is protective in the pyelonephritis stage of ascending UPEC infection, but the role of the haemostatic system has not been investigated during sepsis. Here we utilize a zebrafish-UPEC systemic infection model to visualize infection-induced coagulation and examine the effects of commonly prescribed anti-haemostatic medications on the infection severity. Treatment of systemically infected zebrafish with warfarin, aspirin, or ticagrelor reduced host survival, while stabilization of clots with aminocaproic acid increased host survival. Anti-haemostatic drug treatment increased UPEC burden. Our findings provide evidence that commonly prescribed anti-haemostatic medications may worsen the outcome of severe UPEC infection.

Creators:
Creators
Email
Tran, Vi L.T.
UNSPECIFIED
Hortle, Elinor
UNSPECIFIED
Britton, Warwick J.
UNSPECIFIED
Oehlers, Stefan H.
UNSPECIFIED
Last Modified: 17 Mar 2022 01:55
URI: https://eprints.centenary.org.au/id/eprint/1187

Actions (login required)

View Item View Item